SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 8.53 |
| Enterprise Value ($M) | -6.26 |
| Book Value ($M) | 11.54 |
| Book Value / Share | 0.21 |
| Price / Book | 0.74 |
| NCAV ($M) | -110.81 |
| NCAV / Share | -2.00 |
| Price / NCAV | -0.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -1.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.26 |
| Current Ratio | 1.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 30.38 |
| Assets | 152.73 |
| Liabilities | 141.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Flagship V VentureLabs Rx Fund, L.P. | |||
| 13D/A | Flagship Ventures Fund V, L.P. | |||
| 13G/A | Fmr Llc | 10.68 | 11.39 | |
| 13G/A | HarbourVest Partners L.P. | 6.40 | 32.68 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,400,275 | 19,571,270 | 42.92 | |
| 798,463 | 2,925,923 | 27.29 | |
| 1,665,897 | 3,538,441 | 47.08 | |
| 1,879,142 | 4,735,882 | 39.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NXTC – NextCure, Inc. | OGI – Organigram Holdings Inc. |
| OLMA – Olema Pharmaceuticals, Inc. | OPK – OPKO Health, Inc. |
| OPTN – OptiNose, Inc. |
Financial data and stock pages provided by
Fintel.io